Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-02-10

FDA Approved: OLANZAPINE — Supplemental Application (Dr.Reddy's Laboratories Limited)

View source ↗

Summary

FDA approved a supplemental application for olanzapine from Dr. Reddy's Laboratories Limited (ANDA 076534), authorizing a generic olanzapine product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • olanzapine (olanzapine)

Snippet

SUPPL AP for OLANZAPINE (OLANZAPINE)